- Home
- DX vs PRCT Comparison
DX vs PRCT Comparison
Compare DX & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DX | PRCT |
|---|---|---|
| Founded | 1987 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | DX | PRCT |
|---|---|---|
| Price | $13.88 | $32.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $13.83 | ★ $51.13 |
| AVG Volume (30 Days) | ★ 4.2M | 1.4M |
| Earning Date | 01-26-2026 | 11-04-2025 |
| Dividend Yield | ★ 14.62% | N/A |
| EPS Growth | ★ 35.65 | N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | $230,447,000.00 | ★ $299,907,000.00 |
| Revenue This Year | N/A | $48.30 |
| Revenue Next Year | $134.14 | $29.44 |
| P/E Ratio | $8.41 | ★ N/A |
| Revenue Growth | ★ 87.09 | 50.07 |
| 52 Week Low | $10.79 | $27.80 |
| 52 Week High | $14.52 | $89.49 |
Technical Indicators
Market Signals| Indicator | DX | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 56.55 | 46.15 |
| Support Level | $13.81 | $31.70 |
| Resistance Level | $13.98 | $34.88 |
| Average True Range (ATR) | 0.18 | 1.63 |
| MACD | 0.00 | -0.27 |
| Stochastic Oscillator | 69.83 | 13.00 |
Price Performance
Historical ComparisonAbout DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.